A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities

Chronic myeloid leukemia (CML), a myeloproliferative disorder caused by the over activity of BCR-ABL1 (breakpoint cluster region-Abelson), has been successfully treated by Tyrosine kinase inhibitors (TKIs). While imatinib is known as the first-line treatment of CML, in some cases other TKIs includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nekoukar, Zahra, Moghimi, Minoo, Salehifar, Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721448/
https://www.ncbi.nlm.nih.gov/pubmed/34776414
http://dx.doi.org/10.5045/br.2021.2021117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721448/
https://www.ncbi.nlm.nih.gov/pubmed/34776414
http://dx.doi.org/10.5045/br.2021.2021117

Ejemplares similares